<DOC>
	<DOC>NCT00485225</DOC>
	<brief_summary>Two stage study looking at different titration schedules in patients with moderate to severe non-malignant chronic pain. Up to 80 patients at approximately 15 centers in the US to be enrolled. Study participation is approximately 3 months.</brief_summary>
	<brief_title>Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<criteria>Opioid experienced Hx (min 3 months) of moderate to severe pain of nonmalignant that is well controlled with current pain therapy On a stable dose of opioid medication for greater than or equal to 14 days Have an adequate personal support system including a cohabitant Are able and willing to follow verbal and written instructions and provide written informed consent Are pregnant or lactating Have pain secondary to a confirmed or suspected neoplasm Have a history or physical examination finding incompatible with safe participation in the study Have a history of alcohol or drug abuse Have a history or physical examination finding of clinically significant skin abnormalities that would preclude use of a transdermal patch (e.g., psoriasis) Have a history of or currently manifesting a clinically significant psychiatric disorder Have a known history of allergy that negatively impacts respiratory function to a clinically significant level Plan to have an MRI while on the study Have any clinically significant condition that would, in the opinion of the investigator, preclude safe study participation Are scheduled for surgery requiring general anesthesia within the study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>